News from members
- Svein Lien utnevnt til ny administrerende direktør i Biotec Pharmacon ASA
- Svein Lien appointed new CEO of Biotec Pharmacon ASA
- PharmaLive: Inovio Biomedical to Present at Roth Capital Partners Growth Stock Investor Conference
- Inovio Biomedical Corporation to Present atCapital Partners Growth Stock Investor Conference
- Inovio Biomedical to Present at Roth Capital Partners Growth Stock Investor Conference
- Biotec Pharmacon presenting re-established platform at BIO-Europe
- Biotec Pharmacon presenting re-established plat...
- Inovio Releases Cordless Electroporation Device for Delivering DNA Vaccines
- Inovio Intros Cordless Electroporation Device for Delivering DNA Vaccines
- Inovio develops hand-held device for mass vaccination
- Algeta ASA (NO) - New clinical analyses from Alpharadin clinical programs to be presented at 2010 Genitourinary Cancers Symposium
- PharmaLive: Algeta ASA (NO) - New clinical analyses from Alpharadin clinical programs to be presented at 2010 Genitourinary Cancers Symposium
- PharmaLive: Algeta ASA (NO) - Algeta to present at Cowen's 30th Annual Health Care Conference
- Algeta to present at Cowen's 30th Annual Health...
- Algeta to present at Cowen´s 30th Annual Health Care Conference
- BiomedReports: News and FDA Updates for ImmunoCellular (OTC:IMUC), Impax (NASDAQ:IPXL), Inovio (NYSE:INO)
- Inovio Biomedical Corporation Develops Cordless Electroporation Device for Delivering DNA Vaccines
- Inovio Biomedical unveils CELLECTRA-SP cordless electroporation device
- Inovio Biomedical introduces new CELLECTRA-SP series of hand-held, cordless electroporation devices
- Inovio Biomedical receives Korean approval for Phase I clinical trial of DNA vaccine
- Inovio Develops Cordless Electroporation Device for Delivering DNA Vaccines
- Inovio Develops Cordless Electroporation Device for Delivering DNA Vaccines | Business Wire
- PharmaLive: Inovio's H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials
- Inovio Biomedical Corporation H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials
- PharmaLive: Inovio Biomedical H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials
- Inovio Biomedical Obtains Korean Approval To Initiate VGX-3400 Clinical Trial
- Inovio Biomedical Corp secures Korean approvalÃ? to beginÃ? clinical trials for SynCon universal flu vaccine
- Inovio Biomedical H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials
- Peregrine Pharmaceuticals Licenses Anti-VEGF Antibodies to Affitech
- Inovio Biomedical H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials | Business Wire
- PharmaLive: Algeta ASA (NO) - Save the Dates: Algeta to host Capital Markets Days in Oslo (25 May) and London (27 May)
- Save the Dates: Algeta to host Capital Markets ...
- Save the Dates: Algeta to host Capital Markets Days in Oslo (25 May) and London (27 May)
- Aker BioMarine
- PharmaLive: Biotec Pharmacon ASA (NO) - Interim Results for the Fourth Quarter and Full Year 2009
- Inovio Biomedical Appoints Dr. Iacob Mathiesen To Its Scientific Advisory Board
- PharmaLive: Inovio Biomedical to Present at DNA Vaccines 2010 Conference
- Axis-Shield Reports Profit Of GBP5.5 Million In H1 2009
- Skymark Research Initiates Independent Research Coverage on Inovio Biomedical Corporation
- Inovio Biomedical Corporation to Present at2010 Conference
- Inovio Biomedical to Present at DNA Vaccines 2010 Conference | Business Wire
- Inovio Biomedical to Present at DNA Vaccines 2010 Conference
- Affitech A/S Company Announcement Affitech Restructures License Deal with KAEL-GemVax
- DiaGenic ASA - Share capital increase
- PharmaLive: Biotec Pharmacon ASA (NO) - Testing SBG packaging containers after weak results from oral mucositis study
- PharmaLive: Algeta ASA (NO) - Algeta Results for the Fourth Quarter and Full Year 2009
- Resolution to increase the share capital in Algeta ASA
- Norwegian PCI Biotech Q4 '09 net loss narrows
- Norwegian Photocure Q4 loss widens
- Algeta Results for the Fourth Quarter and Full ...
- Svein Lien utnevnt til ny administrerende direktør i Biotec Pharmacon ASA
- Svein Lien appointed new CEO of Biotec Pharmacon ASA
- PharmaLive: Inovio Biomedical to Present at Roth Capital Partners Growth Stock Investor Conference
- Inovio Biomedical Corporation to Present atCapital Partners Growth Stock Investor Conference
- Inovio Biomedical to Present at Roth Capital Partners Growth Stock Investor Conference
- Biotec Pharmacon presenting re-established platform at BIO-Europe
- Biotec Pharmacon presenting re-established plat...
- Inovio Releases Cordless Electroporation Device for Delivering DNA Vaccines
- Inovio Intros Cordless Electroporation Device for Delivering DNA Vaccines
- Inovio develops hand-held device for mass vaccination
- Algeta ASA (NO) - New clinical analyses from Alpharadin clinical programs to be presented at 2010 Genitourinary Cancers Symposium
- PharmaLive: Algeta ASA (NO) - New clinical analyses from Alpharadin clinical programs to be presented at 2010 Genitourinary Cancers Symposium
- PharmaLive: Algeta ASA (NO) - Algeta to present at Cowen's 30th Annual Health Care Conference
- Algeta to present at Cowen's 30th Annual Health...
- Algeta to present at Cowen´s 30th Annual Health Care Conference
- BiomedReports: News and FDA Updates for ImmunoCellular (OTC:IMUC), Impax (NASDAQ:IPXL), Inovio (NYSE:INO)
- Inovio Biomedical Corporation Develops Cordless Electroporation Device for Delivering DNA Vaccines
- Inovio Biomedical unveils CELLECTRA-SP cordless electroporation device
- Inovio Biomedical introduces new CELLECTRA-SP series of hand-held, cordless electroporation devices
- Inovio Biomedical receives Korean approval for Phase I clinical trial of DNA vaccine
- Inovio Develops Cordless Electroporation Device for Delivering DNA Vaccines
- Inovio Develops Cordless Electroporation Device for Delivering DNA Vaccines | Business Wire
- PharmaLive: Inovio's H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials
- Inovio Biomedical Corporation H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials
- PharmaLive: Inovio Biomedical H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials
- Inovio Biomedical Obtains Korean Approval To Initiate VGX-3400 Clinical Trial
- Inovio Biomedical Corp secures Korean approvalÃ? to beginÃ? clinical trials for SynCon universal flu vaccine
- Inovio Biomedical H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials
- Peregrine Pharmaceuticals Licenses Anti-VEGF Antibodies to Affitech
- Inovio Biomedical H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials | Business Wire
- PharmaLive: Algeta ASA (NO) - Save the Dates: Algeta to host Capital Markets Days in Oslo (25 May) and London (27 May)
- Save the Dates: Algeta to host Capital Markets ...
- Save the Dates: Algeta to host Capital Markets Days in Oslo (25 May) and London (27 May)
- Aker BioMarine
- PharmaLive: Biotec Pharmacon ASA (NO) - Interim Results for the Fourth Quarter and Full Year 2009
- Inovio Biomedical Appoints Dr. Iacob Mathiesen To Its Scientific Advisory Board
- PharmaLive: Inovio Biomedical to Present at DNA Vaccines 2010 Conference
- Axis-Shield Reports Profit Of GBP5.5 Million In H1 2009
- Skymark Research Initiates Independent Research Coverage on Inovio Biomedical Corporation
- Inovio Biomedical Corporation to Present at2010 Conference
- Inovio Biomedical to Present at DNA Vaccines 2010 Conference | Business Wire
- Inovio Biomedical to Present at DNA Vaccines 2010 Conference
- Affitech A/S Company Announcement Affitech Restructures License Deal with KAEL-GemVax
- DiaGenic ASA - Share capital increase
- PharmaLive: Biotec Pharmacon ASA (NO) - Testing SBG packaging containers after weak results from oral mucositis study
- PharmaLive: Algeta ASA (NO) - Algeta Results for the Fourth Quarter and Full Year 2009
- Resolution to increase the share capital in Algeta ASA
- Norwegian PCI Biotech Q4 '09 net loss narrows
- Norwegian Photocure Q4 loss widens
- Algeta Results for the Fourth Quarter and Full ...
- Svein Lien utnevnt til ny administrerende direktør i Biotec Pharmacon ASA
- Svein Lien appointed new CEO of Biotec Pharmacon ASA
- PharmaLive: Inovio Biomedical to Present at Roth Capital Partners Growth Stock Investor Conference
- Inovio Biomedical Corporation to Present atCapital Partners Growth Stock Investor Conference
- Inovio Biomedical to Present at Roth Capital Partners Growth Stock Investor Conference
- Biotec Pharmacon presenting re-established platform at BIO-Europe
- Biotec Pharmacon presenting re-established plat...
- Inovio Releases Cordless Electroporation Device for Delivering DNA Vaccines
- Inovio Intros Cordless Electroporation Device for Delivering DNA Vaccines
- Inovio develops hand-held device for mass vaccination
- Algeta ASA (NO) - New clinical analyses from Alpharadin clinical programs to be presented at 2010 Genitourinary Cancers Symposium
- PharmaLive: Algeta ASA (NO) - New clinical analyses from Alpharadin clinical programs to be presented at 2010 Genitourinary Cancers Symposium
- PharmaLive: Algeta ASA (NO) - Algeta to present at Cowen's 30th Annual Health Care Conference
- Algeta to present at Cowen's 30th Annual Health...
- Algeta to present at Cowen´s 30th Annual Health Care Conference
- BiomedReports: News and FDA Updates for ImmunoCellular (OTC:IMUC), Impax (NASDAQ:IPXL), Inovio (NYSE:INO)
- Inovio Biomedical Corporation Develops Cordless Electroporation Device for Delivering DNA Vaccines
- Inovio Biomedical unveils CELLECTRA-SP cordless electroporation device
- Inovio Biomedical introduces new CELLECTRA-SP series of hand-held, cordless electroporation devices
- Inovio Biomedical receives Korean approval for Phase I clinical trial of DNA vaccine
- Inovio Develops Cordless Electroporation Device for Delivering DNA Vaccines
- Inovio Develops Cordless Electroporation Device for Delivering DNA Vaccines | Business Wire
- PharmaLive: Inovio's H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials
- Inovio Biomedical Corporation H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials
- PharmaLive: Inovio Biomedical H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials
- Inovio Biomedical Obtains Korean Approval To Initiate VGX-3400 Clinical Trial
- Inovio Biomedical Corp secures Korean approvalÃ? to beginÃ? clinical trials for SynCon universal flu vaccine
- Inovio Biomedical H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials
- Peregrine Pharmaceuticals Licenses Anti-VEGF Antibodies to Affitech
- Inovio Biomedical H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials | Business Wire
- PharmaLive: Algeta ASA (NO) - Save the Dates: Algeta to host Capital Markets Days in Oslo (25 May) and London (27 May)
- Save the Dates: Algeta to host Capital Markets ...
- Save the Dates: Algeta to host Capital Markets Days in Oslo (25 May) and London (27 May)
- Aker BioMarine
- PharmaLive: Biotec Pharmacon ASA (NO) - Interim Results for the Fourth Quarter and Full Year 2009
- Inovio Biomedical Appoints Dr. Iacob Mathiesen To Its Scientific Advisory Board
- PharmaLive: Inovio Biomedical to Present at DNA Vaccines 2010 Conference
- Axis-Shield Reports Profit Of GBP5.5 Million In H1 2009
- Skymark Research Initiates Independent Research Coverage on Inovio Biomedical Corporation
- Inovio Biomedical Corporation to Present at2010 Conference
- Inovio Biomedical to Present at DNA Vaccines 2010 Conference | Business Wire
- Inovio Biomedical to Present at DNA Vaccines 2010 Conference
- Affitech A/S Company Announcement Affitech Restructures License Deal with KAEL-GemVax
- DiaGenic ASA - Share capital increase
- PharmaLive: Biotec Pharmacon ASA (NO) - Testing SBG packaging containers after weak results from oral mucositis study
- PharmaLive: Algeta ASA (NO) - Algeta Results for the Fourth Quarter and Full Year 2009
- Resolution to increase the share capital in Algeta ASA
- Norwegian PCI Biotech Q4 '09 net loss narrows
- Norwegian Photocure Q4 loss widens
- Algeta Results for the Fourth Quarter and Full ...
- Svein Lien utnevnt til ny administrerende direktør i Biotec Pharmacon ASA
- Svein Lien appointed new CEO of Biotec Pharmacon ASA
- PharmaLive: Inovio Biomedical to Present at Roth Capital Partners Growth Stock Investor Conference
- Inovio Biomedical Corporation to Present atCapital Partners Growth Stock Investor Conference
- Inovio Biomedical to Present at Roth Capital Partners Growth Stock Investor Conference
- Biotec Pharmacon presenting re-established platform at BIO-Europe
- Biotec Pharmacon presenting re-established plat...
- Inovio Releases Cordless Electroporation Device for Delivering DNA Vaccines
- Inovio Intros Cordless Electroporation Device for Delivering DNA Vaccines
- Inovio develops hand-held device for mass vaccination
- Algeta ASA (NO) - New clinical analyses from Alpharadin clinical programs to be presented at 2010 Genitourinary Cancers Symposium
- PharmaLive: Algeta ASA (NO) - New clinical analyses from Alpharadin clinical programs to be presented at 2010 Genitourinary Cancers Symposium
- PharmaLive: Algeta ASA (NO) - Algeta to present at Cowen's 30th Annual Health Care Conference
- Algeta to present at Cowen's 30th Annual Health...
- Algeta to present at Cowen´s 30th Annual Health Care Conference
- BiomedReports: News and FDA Updates for ImmunoCellular (OTC:IMUC), Impax (NASDAQ:IPXL), Inovio (NYSE:INO)
- Inovio Biomedical Corporation Develops Cordless Electroporation Device for Delivering DNA Vaccines
- Inovio Biomedical unveils CELLECTRA-SP cordless electroporation device
- Inovio Biomedical introduces new CELLECTRA-SP series of hand-held, cordless electroporation devices
- Inovio Biomedical receives Korean approval for Phase I clinical trial of DNA vaccine
- Inovio Develops Cordless Electroporation Device for Delivering DNA Vaccines
- Inovio Develops Cordless Electroporation Device for Delivering DNA Vaccines | Business Wire
- PharmaLive: Inovio's H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials
- Inovio Biomedical Corporation H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials
- PharmaLive: Inovio Biomedical H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials
- Inovio Biomedical Obtains Korean Approval To Initiate VGX-3400 Clinical Trial
- Inovio Biomedical Corp secures Korean approvalÃ? to beginÃ? clinical trials for SynCon universal flu vaccine
- Inovio Biomedical H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials
- Peregrine Pharmaceuticals Licenses Anti-VEGF Antibodies to Affitech
- Inovio Biomedical H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials | Business Wire
- PharmaLive: Algeta ASA (NO) - Save the Dates: Algeta to host Capital Markets Days in Oslo (25 May) and London (27 May)
- Save the Dates: Algeta to host Capital Markets ...
- Save the Dates: Algeta to host Capital Markets Days in Oslo (25 May) and London (27 May)
- Aker BioMarine
- PharmaLive: Biotec Pharmacon ASA (NO) - Interim Results for the Fourth Quarter and Full Year 2009
- Inovio Biomedical Appoints Dr. Iacob Mathiesen To Its Scientific Advisory Board
- PharmaLive: Inovio Biomedical to Present at DNA Vaccines 2010 Conference
- Axis-Shield Reports Profit Of GBP5.5 Million In H1 2009
- Skymark Research Initiates Independent Research Coverage on Inovio Biomedical Corporation
- Inovio Biomedical Corporation to Present at2010 Conference
- Inovio Biomedical to Present at DNA Vaccines 2010 Conference | Business Wire
- Inovio Biomedical to Present at DNA Vaccines 2010 Conference
- Affitech A/S Company Announcement Affitech Restructures License Deal with KAEL-GemVax
- DiaGenic ASA - Share capital increase
- PharmaLive: Biotec Pharmacon ASA (NO) - Testing SBG packaging containers after weak results from oral mucositis study
- PharmaLive: Algeta ASA (NO) - Algeta Results for the Fourth Quarter and Full Year 2009
- Resolution to increase the share capital in Algeta ASA
- Norwegian PCI Biotech Q4 '09 net loss narrows
- Norwegian Photocure Q4 loss widens
- Algeta Results for the Fourth Quarter and Full ...
- Svein Lien utnevnt til ny administrerende direktør i Biotec Pharmacon ASA
- Svein Lien appointed new CEO of Biotec Pharmacon ASA
- PharmaLive: Inovio Biomedical to Present at Roth Capital Partners Growth Stock Investor Conference
- Inovio Biomedical Corporation to Present atCapital Partners Growth Stock Investor Conference
- Inovio Biomedical to Present at Roth Capital Partners Growth Stock Investor Conference
- Biotec Pharmacon presenting re-established platform at BIO-Europe
- Biotec Pharmacon presenting re-established plat...
- Inovio Releases Cordless Electroporation Device for Delivering DNA Vaccines
- Inovio Intros Cordless Electroporation Device for Delivering DNA Vaccines
- Inovio develops hand-held device for mass vaccination
- Algeta ASA (NO) - New clinical analyses from Alpharadin clinical programs to be presented at 2010 Genitourinary Cancers Symposium
- PharmaLive: Algeta ASA (NO) - New clinical analyses from Alpharadin clinical programs to be presented at 2010 Genitourinary Cancers Symposium
- PharmaLive: Algeta ASA (NO) - Algeta to present at Cowen's 30th Annual Health Care Conference
- Algeta to present at Cowen's 30th Annual Health...
- Algeta to present at Cowen´s 30th Annual Health Care Conference
- BiomedReports: News and FDA Updates for ImmunoCellular (OTC:IMUC), Impax (NASDAQ:IPXL), Inovio (NYSE:INO)
- Inovio Biomedical Corporation Develops Cordless Electroporation Device for Delivering DNA Vaccines
- Inovio Biomedical unveils CELLECTRA-SP cordless electroporation device
- Inovio Biomedical introduces new CELLECTRA-SP series of hand-held, cordless electroporation devices
- Inovio Biomedical receives Korean approval for Phase I clinical trial of DNA vaccine
- Inovio Develops Cordless Electroporation Device for Delivering DNA Vaccines
- Inovio Develops Cordless Electroporation Device for Delivering DNA Vaccines | Business Wire
- PharmaLive: Inovio's H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials
- Inovio Biomedical Corporation H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials
- PharmaLive: Inovio Biomedical H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials
- Inovio Biomedical Obtains Korean Approval To Initiate VGX-3400 Clinical Trial
- Inovio Biomedical Corp secures Korean approvalÃ? to beginÃ? clinical trials for SynCon universal flu vaccine
- Inovio Biomedical H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials
- Peregrine Pharmaceuticals Licenses Anti-VEGF Antibodies to Affitech
- Inovio Biomedical H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials | Business Wire
- PharmaLive: Algeta ASA (NO) - Save the Dates: Algeta to host Capital Markets Days in Oslo (25 May) and London (27 May)
- Save the Dates: Algeta to host Capital Markets ...
- Save the Dates: Algeta to host Capital Markets Days in Oslo (25 May) and London (27 May)
- Aker BioMarine
- PharmaLive: Biotec Pharmacon ASA (NO) - Interim Results for the Fourth Quarter and Full Year 2009
- Inovio Biomedical Appoints Dr. Iacob Mathiesen To Its Scientific Advisory Board
- PharmaLive: Inovio Biomedical to Present at DNA Vaccines 2010 Conference
- Axis-Shield Reports Profit Of GBP5.5 Million In H1 2009
- Skymark Research Initiates Independent Research Coverage on Inovio Biomedical Corporation
- Inovio Biomedical Corporation to Present at2010 Conference
- Inovio Biomedical to Present at DNA Vaccines 2010 Conference | Business Wire
- Inovio Biomedical to Present at DNA Vaccines 2010 Conference
- Affitech A/S Company Announcement Affitech Restructures License Deal with KAEL-GemVax
- DiaGenic ASA - Share capital increase
- PharmaLive: Biotec Pharmacon ASA (NO) - Testing SBG packaging containers after weak results from oral mucositis study
- PharmaLive: Algeta ASA (NO) - Algeta Results for the Fourth Quarter and Full Year 2009
- Resolution to increase the share capital in Algeta ASA
- Norwegian PCI Biotech Q4 '09 net loss narrows
- Norwegian Photocure Q4 loss widens
- Algeta Results for the Fourth Quarter and Full ...
-
Welcome to Life Science Support Office!
Life Science Support Office, LSSO, is a part of Norwegian Bioindustry Association. It was established in close collaboration with the Norwegian Research Council in 2008. LSSO aims to guide biotech SMEs and support their participation in EU-funded research projects.
>> Read more08.12.08 -
The EUREKA network and the Eurostars programme
EUREKA is an intergovernmental network of 39 members with the objective to stimulate R&D-performing businesses. EUREKA support research-performing SME through its Eurostars programme which is dedicated to fund collaborative research and innovation projects.
>> Read more15.02.10
Norwegian Bioindustry Association
Middelthuns gt. 27, Postboks 7072 Majorstuen, NO-0306 Oslo Tel: +47 23 08 88 00 / +47 23 08 88 18 / +47 91 10 54 91 Email: biotek@norskindustri.no Fax: +47 23 08 88 98